SINOVAC GETS WHO EMERGENCY APPROVAL
- June 2, 2021
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
SINOVAC GETS WHO EMERGENCY APPROVAL
Subject: Science & tech
Context: Recently, the World Health Organization (WHO) has approved China’s Sinovac Covid vaccine for emergency use.
Concept:
About Sinovac Vaccine
- It is an inactivated vaccine.
- It works by using killed viral particles to expose the body’s immune system to the virus without risking a serious disease response.
- The Beijing-based biopharmaceutical company Sinovac is behind the CoronaVac.
- It is the second Chinese vaccine to receive the green light from the WHO, after Sinopharm.
- It is a more traditional method of vaccine that is successfully used in many well-known vaccines like rabies.
- One of Sinovac’s main advantages is that it can be stored in a standard refrigerator at 2-8 degrees Celsius.
- It implies that Sinovac is a lot more useful to developing countries which might not be able to store large amounts of vaccine at low temperatures.
- The Strategic Advisory Group of Experts on Immunization recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks.